Cormorant Asset Management, Lp
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$1.99B
Q ending 2026-03-31
Prior quarter
$2.16B
Q ending 2025-12-31
Change
-7.9% QoQ · +49.7% YoY
Positions
47
reported holdings
Largest positions
All 47 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Praxis Precision Medicines I | PRAX | Shares | $285.3M | 886K |
| Bridgebio Oncology Therapeut | BBOT | Shares | $160.0M | 17.9M |
| Eyepoint Inc | EYPT | Shares | $106.5M | 8.3M |
| Edgewise Therapeutics Inc | EWTX | Shares | $102.7M | 3.3M |
| Erasca Inc | ERAS | Shares | $93.8M | 5.8M |
| Rapport Therapeutics Inc | RAPP | Shares | $92.5M | 3.0M |
| Alumis Inc | ALMS | Shares | $87.0M | 3.9M |
| Abivax Sa | ABVX | Shares | $84.6M | 760K |
| Moonlake Immunotherapeutics | MLTX | Shares | $83.5M | 4.5M |
| Dianthus Therapeutics Inc | DNTH | Shares | $79.7M | 950K |
| Bright Minds Biosciences Inc | DRUG | Shares | $77.3M | 1.1M |
| Bridgebio Pharma Inc | BBIO | Shares | $63.1M | 850K |
| Olema Pharmaceuticals Inc | OLMA | Shares | $58.1M | 3.9M |
| Bioage Labs Inc | BIOA | Shares | $50.6M | 2.9M |
| Centessa Pharmaceuticals Plc | 260 | Shares | $41.7M | 1.1M |
| Damora Therapeutics Inc | DMRA | Shares | $39.5M | 1.5M |
| Mbx Biosciences Inc | MBX | Shares | $33.4M | 1.1M |
| Insmed Inc | INSM | Shares | $31.1M | 190K |
| Newamsterdam Pharma Company | Shares | $30.4M | 950K | |
| Tango Therapeutics Inc | TNGX | Shares | $29.8M | 1.4M |
| Pharvaris N V | Shares | $28.3M | 1.0M | |
| Oruka Therapeutics Inc | ORKA | Shares | $26.2M | 533K |
| Agomab Therapeutics Nv | AGMB | Shares | $25.9M | 2.5M |
| Maze Therapeutics Inc | MAZE | Shares | $22.4M | 750K |
| Corbus Pharmaceuticals Hldgs | CRBP | Shares | $22.0M | 2.3M |
| Ascendis Pharma A/S | Shares | $21.7M | 95K | |
| Roivant Sciences Ltd | Shares | $20.8M | 750K | |
| Adlai Nortye Ltd | ANL | Shares | $20.1M | 2.9M |
| Terns Pharmaceuticals Inc | 430 | Shares | $15.8M | 300K |
| Tarsus Pharmaceuticals Inc | TARS | Shares | $15.8M | 225K |
| Biohaven Ltd | Shares | $14.9M | 1.8M | |
| Cabaletta Bio Inc | CABA | Shares | $14.8M | 5.5M |
| Helix Acquisition Corp Iii | Shares | $13.2M | 1.3M | |
| Arcutis Biotherapeutics Inc | ARQT | Shares | $10.6M | 450K |
| Sensei Biotherapeutics Inc | FTH | Shares | $9.7M | 306K |
| Crinetics Pharmaceuticals In | CRNX | Shares | $9.1M | 250K |
| Zura Bio Ltd | Shares | $8.6M | 1.4M | |
| Axsome Therapeutics Inc. | AXSM | Shares | $8.5M | 50K |
| Structure Therapeutics Inc | GPCR | Shares | $8.4M | 175K |
| Cogent Biosciences Inc | COGT | Shares | $7.7M | 200K |
| Olema Pharmaceuticals Inc | OLMA | Call | $7.5M | 500K |
| Monte Rosa Therapeutics Inc | GLUE | Shares | $6.6M | 400K |
| Arrowhead Pharmaceuticals In | ARWR | Shares | $6.3M | 100K |
| Vaxcyte Inc | PCVX | Shares | $5.8M | 100K |
| Amylyx Pharmaceuticals Inc | AMLX | Shares | $4.9M | 350K |
| Rallybio Corp | RLYB | Shares | $3.6M | 400K |
| Context Therapeutics Inc | CNTX | Shares | $1.4M | 530K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.